查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513327

人工心臟瓣膜市場（按產品）：2024-2035 年全球機會分析與產業預測

Prosthetic Heart Valve Market By Product (Mechanical Heart Valve, Tissue Heart Valve, Transcatheter Heart Valve): Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 212 Pages | 商品交期: 2-3個工作天內

價格
2023年人工心臟瓣膜市場價值為86億美元，預計到2035年將達到303億美元，2024年至2035年的複合年成長率為11.1%。人工心臟瓣膜人工取代受損或生病的心臟瓣膜，是調節流入和流出心室的血液的重要組成部分。這些瓣膜的故障會導致各種心血管問題，包括呼吸急促、疲勞、胸痛，甚至心臟衰竭。人工心臟瓣膜旨在模仿健康心臟瓣膜的功能，促進全身正常的血液循環。人工心臟瓣膜的主要類型包括機械心臟瓣膜、組織心臟瓣膜和經導管心臟瓣膜。
人工心臟瓣膜市場-IMG1
人工心臟瓣膜市場的成長主要是由於心臟瓣膜疾病的日益普及、心臟瓣膜技術的進步以及對微創手術的需求不斷增加所推動的。例如，根據美國心臟學會（2021）的數據，美國每年有超過 500 萬人被診斷出患有瓣膜性心臟病（VHD），而瓣膜性心臟病（VHD）盛行率的上升正在推動市場是我們成長的動力。此外，對微創手術的需求迅速成長正在推動經導管心臟瓣膜置換術的採用。這種微創且快速恢復的方法比傳統的心臟直視手術越來越受到青睞，並正在推動市場成長。此外，全球心臟瓣膜手術數量的增加預計也將推動人工心臟瓣膜市場的成長。例如，根據美國國家醫學圖書館 2022 年發表的一篇論文，全球每年進行 20 萬例心臟瓣膜置換手術，預計到 2050 年將增加到 85 萬例。因此，心臟瓣膜手術數量的增加將導致對人工心臟瓣膜的需求，推動市場成長。人口老化是一種全球現象，這種人口變化預計將在預測期內繼續推動人造心臟瓣膜的需求。心臟病的增加推動了對用於治療各種心臟瓣膜疾病的人工心臟瓣膜的需求，包括主動脈瓣狹窄、二尖瓣狹窄和二尖瓣瓣膜閉鎖不全。除了心臟病患病率迅速上升和人口老化之外，人造心臟瓣膜市場還受到患者意識提高的推動。患者對自己的健康狀況和可用治療方法越來越了解，導致對人工心臟瓣膜作為安全有效的瓣膜性心臟病治療方法的需求增加。此外，政府的措施和人們對瓣膜性心臟病的認知不斷提高正在推動市場的成長。世界各國政府都在投資研究和開發瓣膜性心臟病的新治療方法，從而促進了先進人造心臟瓣膜裝置的開發。此外，人們對與瓣膜性心臟病相關的症狀和風險因素的認知不斷提高，導致尋求瓣膜性心臟病治療的人數增加，進一步推動了市場成長。人造心臟瓣膜市場按產品和地區細分。依產品分類，可分為機械式心臟瓣膜、組織心臟瓣膜及經導管心臟瓣膜。組織瓣膜又分為帶組織瓣膜和無支架組織瓣膜。依地區分類，市場分為北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙、其他歐洲國家）、亞太地區（日本、中國、澳洲、印度、韓國、其他地區）亞太地區））和南美地區（巴西、沙烏地阿拉伯、非洲和其他南美地區）。全球人造心臟瓣膜市場的主要企業包括雅培實驗室、波士頓科學公司、ShockWave Medical, Inc.、Edward Lifesciences Corporation、Colibri Heart Valve、Medtronic plc、Meril Life Sciences Pvt. Ltd.、Labcor Laboratorios Ltda、Artivion、 Inc . 和JenaValve Technology, Inc.市場上的主要企業已採用協議、產品發布、產品核可和品牌重塑作為擴大產品系列的關鍵策略。

相關人員的主要利益

  • 該報告提供了 2023 年至 2035 年人工心臟瓣膜市場分析的細分市場、當前趨勢、估計/趨勢和動態的定量分析，並確定了一般人工心臟瓣膜市場的機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析強調買家和供應商幫助相關人員做出利潤驅動的商業決策並加強供應商和買家網路的潛力。
  • 對人工心臟瓣膜市場細分的詳細分析將有助於確定市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前位置的清晰了解。
  • 該報告包括對區域和全球人工心臟瓣膜市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章人工心臟瓣膜市場：依產品

  • 概述
  • 機械心臟瓣膜
  • 組織心臟瓣膜
    • 組織心臟瓣膜人工心臟瓣膜市場，依類型
  • 經導管心臟瓣膜

第5章人工心臟瓣膜市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第6章 競爭狀況

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2023年主要企業定位

第7章 公司簡介

  • Meril Life Sciences Pvt. Ltd.
  • Abbott Laboratories
  • Labcor Laboratorios Ltda
  • Artivion, Inc.
  • Boston Scientific Corporation
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • ShockWave Medical, Inc.
  • Medtronic plc
  • JenaValve Technology, Inc.
Product Code: A01846
The prosthetic heart valve market was valued at $8.6 billion in 2023 and is projected to reach $30.3 billion by 2035, registering a CAGR of 11.1% from 2024 to 2035. Prosthetic heart valves serve as synthetic replacements for damaged or diseased heart valves, crucial components that regulate blood flow in and out of the heart's chambers. Dysfunction in these valves can lead to a spectrum of cardiovascular issues, including shortness of breath, fatigue, chest pain, and even heart failure. Designed to mimic the functionality of healthy heart valves, prosthetic heart valves facilitate proper blood circulation throughout the body. The primary types of prosthetic heart valves are mechanical heart valves, tissue heart valves, and transcatheter heart valves.
Prosthetic Heart Valve Market - IMG1
The growth of the prosthetic heart valve market is primarily driven by increasing prevalence of heart valve diseases, technological advancements in heart valves, and increase in demand for minimally invasive procedures. For instance, according to American College of Cardiology 2021, more than 5 million people are diagnosed with valvular heart diseases (VHD) each year in the U.S. Thus, rise in prevalence of valvular heart diseases (VHD) drives the market growth. In addition, surge in demand for minimally invasive procedures, propelling the adoption of transcatheter heart valve replacement. This approach, highlighted for its reduced invasiveness and quicker recovery, has become increasingly favored over traditional open-heart surgery, driving market growth. Furthermore, a rise in the number of heart valve surgeries across the world is expected to boost the growth of the prosthetic heart valve market. For instance, an article published by National Library of Medicine in 2022, 200,000 heart valve replacement surgeries are performed annually worldwide, and is expected to increase to 8,50,000 by 2050, Thus, rise in number of heart valve surgeries results in demand for prosthetic heart valve and fuels the market growth. The aging of the population is a global phenomenon, and this demographic shift is expected to continue to drive demand for these prosthetic heart valve devices during the forecast period. This increase in cardiac disorders drives the demand for prosthetic heart valves, which are used to treat a range of heart valve diseases, including aortic stenosis, mitral stenosis, and mitral regurgitation. In addition to the surge in prevalence of cardiac disorders and the aging of the population, the prosthetic heart valve market is being driven by increased patient awareness. Patients have become more informed about their health and the available treatment options, and this is leading to increased demand for prosthetic heart valves as a safe and effective treatment option for heart valve diseases. Moreover, increased government initiatives and awareness regarding heart valve diseases foster the growth of the market. Governments around the world invest in R&D of new treatments for heart valve diseases, which has led to the development of advanced prosthetic heart valve devices. In addition, rise in awareness about the symptoms and risk factors associated with heart valve disease have led to more people seeking medical treatment for the condition, which has further driven the growth of the market. The prosthetic heart valve market is segmented on the basis of product and region. By product, the market is categorized into mechanical heart valve, tissue heart valve, and transcatheter heart valve. The tissue heart valve segment is further classified into stented tissue heart valve and stent less tissue heart valve. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). Major key players that operate in the global prosthetic heart valve market are Abbott Laboratories, Boston Scientific Corporation, ShockWave Medical, Inc., Edward Lifesciences Corporation, Colibri Heart Valve, Medtronic plc, Meril Life Sciences Pvt. Ltd., Labcor Laboratorios Ltda, Artivion, Inc, and JenaValve Technology, Inc. The key players operating in the market have adopted agreement, product launch, product approval, and rebranding as their key strategies to expand their product portfolio

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the prosthetic heart valve market analysis from 2023 to 2035 to identify the prevailing prosthetic heart valve market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the prosthetic heart valve market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global prosthetic heart valve market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Tissue Heart Valve
    • Type
    • Stented Tissue Heart Valve
    • Stentless Tissue Heart Valve
  • Mechanical Heart Valve
  • Transcatheter Heart Valve

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Meril Life Sciences Pvt. Ltd.
    • Abbott Laboratories
    • Labcor Laboratorios Ltda
    • Artivion, Inc.
    • Boston Scientific Corporation
    • LivaNova PLC
    • Edwards Lifesciences Corporation
    • ShockWave Medical, Inc.
    • Medtronic plc
    • JenaValve Technology, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PROSTHETIC HEART VALVE MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Mechanical Heart Valve
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Tissue Heart Valve
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Tissue Heart Valve Prosthetic Heart Valve Market by Type
  • 4.4. Transcatheter Heart Valve
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: PROSTHETIC HEART VALVE MARKET, BY REGION

  • 5.1. Overview
    • 5.1.1. Market size and forecast By Region
  • 5.2. North America
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by Product
    • 5.2.3. Market size and forecast, by country
      • 5.2.3.1. U.S.
      • 5.2.3.1.1. Market size and forecast, by Product
      • 5.2.3.2. Canada
      • 5.2.3.2.1. Market size and forecast, by Product
      • 5.2.3.3. Mexico
      • 5.2.3.3.1. Market size and forecast, by Product
  • 5.3. Europe
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by Product
    • 5.3.3. Market size and forecast, by country
      • 5.3.3.1. Germany
      • 5.3.3.1.1. Market size and forecast, by Product
      • 5.3.3.2. France
      • 5.3.3.2.1. Market size and forecast, by Product
      • 5.3.3.3. UK
      • 5.3.3.3.1. Market size and forecast, by Product
      • 5.3.3.4. Italy
      • 5.3.3.4.1. Market size and forecast, by Product
      • 5.3.3.5. Spain
      • 5.3.3.5.1. Market size and forecast, by Product
      • 5.3.3.6. Rest of Europe
      • 5.3.3.6.1. Market size and forecast, by Product
  • 5.4. Asia-Pacific
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by Product
    • 5.4.3. Market size and forecast, by country
      • 5.4.3.1. Japan
      • 5.4.3.1.1. Market size and forecast, by Product
      • 5.4.3.2. China
      • 5.4.3.2.1. Market size and forecast, by Product
      • 5.4.3.3. India
      • 5.4.3.3.1. Market size and forecast, by Product
      • 5.4.3.4. Australia
      • 5.4.3.4.1. Market size and forecast, by Product
      • 5.4.3.5. South Korea
      • 5.4.3.5.1. Market size and forecast, by Product
      • 5.4.3.6. Rest of Asia-Pacific
      • 5.4.3.6.1. Market size and forecast, by Product
  • 5.5. LAMEA
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by Product
    • 5.5.3. Market size and forecast, by country
      • 5.5.3.1. Brazil
      • 5.5.3.1.1. Market size and forecast, by Product
      • 5.5.3.2. Saudi Arabia
      • 5.5.3.2.1. Market size and forecast, by Product
      • 5.5.3.3. South Africa
      • 5.5.3.3.1. Market size and forecast, by Product
      • 5.5.3.4. Rest of LAMEA
      • 5.5.3.4.1. Market size and forecast, by Product

CHAPTER 6: COMPETITIVE LANDSCAPE

  • 6.1. Introduction
  • 6.2. Top winning strategies
  • 6.3. Product mapping of top 10 player
  • 6.4. Competitive dashboard
  • 6.5. Competitive heatmap
  • 6.6. Top player positioning, 2023

CHAPTER 7: COMPANY PROFILES

  • 7.1. Meril Life Sciences Pvt. Ltd.
    • 7.1.1. Company overview
    • 7.1.2. Key executives
    • 7.1.3. Company snapshot
    • 7.1.4. Operating business segments
    • 7.1.5. Product portfolio
    • 7.1.6. Business performance
    • 7.1.7. Key strategic moves and developments
  • 7.2. Abbott Laboratories
    • 7.2.1. Company overview
    • 7.2.2. Key executives
    • 7.2.3. Company snapshot
    • 7.2.4. Operating business segments
    • 7.2.5. Product portfolio
    • 7.2.6. Business performance
    • 7.2.7. Key strategic moves and developments
  • 7.3. Labcor Laboratorios Ltda
    • 7.3.1. Company overview
    • 7.3.2. Key executives
    • 7.3.3. Company snapshot
    • 7.3.4. Operating business segments
    • 7.3.5. Product portfolio
    • 7.3.6. Business performance
    • 7.3.7. Key strategic moves and developments
  • 7.4. Artivion, Inc.
    • 7.4.1. Company overview
    • 7.4.2. Key executives
    • 7.4.3. Company snapshot
    • 7.4.4. Operating business segments
    • 7.4.5. Product portfolio
    • 7.4.6. Business performance
    • 7.4.7. Key strategic moves and developments
  • 7.5. Boston Scientific Corporation
    • 7.5.1. Company overview
    • 7.5.2. Key executives
    • 7.5.3. Company snapshot
    • 7.5.4. Operating business segments
    • 7.5.5. Product portfolio
    • 7.5.6. Business performance
    • 7.5.7. Key strategic moves and developments
  • 7.6. LivaNova PLC
    • 7.6.1. Company overview
    • 7.6.2. Key executives
    • 7.6.3. Company snapshot
    • 7.6.4. Operating business segments
    • 7.6.5. Product portfolio
    • 7.6.6. Business performance
    • 7.6.7. Key strategic moves and developments
  • 7.7. Edwards Lifesciences Corporation
    • 7.7.1. Company overview
    • 7.7.2. Key executives
    • 7.7.3. Company snapshot
    • 7.7.4. Operating business segments
    • 7.7.5. Product portfolio
    • 7.7.6. Business performance
    • 7.7.7. Key strategic moves and developments
  • 7.8. ShockWave Medical, Inc.
    • 7.8.1. Company overview
    • 7.8.2. Key executives
    • 7.8.3. Company snapshot
    • 7.8.4. Operating business segments
    • 7.8.5. Product portfolio
    • 7.8.6. Business performance
    • 7.8.7. Key strategic moves and developments
  • 7.9. Medtronic plc
    • 7.9.1. Company overview
    • 7.9.2. Key executives
    • 7.9.3. Company snapshot
    • 7.9.4. Operating business segments
    • 7.9.5. Product portfolio
    • 7.9.6. Business performance
    • 7.9.7. Key strategic moves and developments
  • 7.10. JenaValve Technology, Inc.
    • 7.10.1. Company overview
    • 7.10.2. Key executives
    • 7.10.3. Company snapshot
    • 7.10.4. Operating business segments
    • 7.10.5. Product portfolio
    • 7.10.6. Business performance
    • 7.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 02. PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 03. PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 04. GLOBAL TISSUE HEART VALVE PROSTHETIC HEART VALVE MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 05. PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 06. PROSTHETIC HEART VALVE MARKET, BY REGION, 2023-2035 ($MILLION)
  • TABLE 07. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 08. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 09. U.S. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 10. CANADA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 11. MEXICO PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 12. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 13. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 14. GERMANY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 15. FRANCE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 16. UK PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 17. ITALY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 18. SPAIN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 19. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 20. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 21. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 22. JAPAN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 23. CHINA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 24. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 25. AUSTRALIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 26. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 27. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 28. LAMEA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 29. LAMEA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 30. BRAZIL PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 31. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 32. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 33. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 34. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
  • TABLE 35. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 36. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT SEGMENTS
  • TABLE 37. MERIL LIFE SCIENCES PVT. LTD.: SERVICE SEGMENTS
  • TABLE 38. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 39. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIES
  • TABLE 40. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 41. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 42. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 43. ABBOTT LABORATORIES: SERVICE SEGMENTS
  • TABLE 44. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 45. ABBOTT LABORATORIES: KEY STRATEGIES
  • TABLE 46. LABCOR LABORATORIOS LTDA: KEY EXECUTIVES
  • TABLE 47. LABCOR LABORATORIOS LTDA: COMPANY SNAPSHOT
  • TABLE 48. LABCOR LABORATORIOS LTDA: PRODUCT SEGMENTS
  • TABLE 49. LABCOR LABORATORIOS LTDA: SERVICE SEGMENTS
  • TABLE 50. LABCOR LABORATORIOS LTDA: PRODUCT PORTFOLIO
  • TABLE 51. LABCOR LABORATORIOS LTDA: KEY STRATEGIES
  • TABLE 52. ARTIVION, INC.: KEY EXECUTIVES
  • TABLE 53. ARTIVION, INC.: COMPANY SNAPSHOT
  • TABLE 54. ARTIVION, INC.: PRODUCT SEGMENTS
  • TABLE 55. ARTIVION, INC.: SERVICE SEGMENTS
  • TABLE 56. ARTIVION, INC.: PRODUCT PORTFOLIO
  • TABLE 57. ARTIVION, INC.: KEY STRATEGIES
  • TABLE 58. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 59. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 60. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 61. BOSTON SCIENTIFIC CORPORATION: SERVICE SEGMENTS
  • TABLE 62. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 63. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIES
  • TABLE 64. LIVANOVA PLC: KEY EXECUTIVES
  • TABLE 65. LIVANOVA PLC: COMPANY SNAPSHOT
  • TABLE 66. LIVANOVA PLC: PRODUCT SEGMENTS
  • TABLE 67. LIVANOVA PLC: SERVICE SEGMENTS
  • TABLE 68. LIVANOVA PLC: PRODUCT PORTFOLIO
  • TABLE 69. LIVANOVA PLC: KEY STRATEGIES
  • TABLE 70. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 71. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 72. EDWARDS LIFESCIENCES CORPORATION: PRODUCT SEGMENTS
  • TABLE 73. EDWARDS LIFESCIENCES CORPORATION: SERVICE SEGMENTS
  • TABLE 74. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 75. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIES
  • TABLE 76. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 77. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 78. SHOCKWAVE MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 79. SHOCKWAVE MEDICAL, INC.: SERVICE SEGMENTS
  • TABLE 80. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 81. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIES
  • TABLE 82. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 83. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 84. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 85. MEDTRONIC PLC: SERVICE SEGMENTS
  • TABLE 86. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 87. MEDTRONIC PLC: KEY STRATEGIES
  • TABLE 88. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
  • TABLE 89. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
  • TABLE 90. JENAVALVE TECHNOLOGY, INC.: PRODUCT SEGMENTS
  • TABLE 91. JENAVALVE TECHNOLOGY, INC.: SERVICE SEGMENTS
  • TABLE 92. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
  • TABLE 93. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIES

LIST OF FIGURES

  • FIGURE 01. PROSTHETIC HEART VALVE MARKET, 2023-2035
  • FIGURE 02. SEGMENTATION OF PROSTHETIC HEART VALVE MARKET,2023-2035
  • FIGURE 03. TOP IMPACTING FACTORS IN PROSTHETIC HEART VALVE MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN PROSTHETIC HEART VALVE MARKET (2024-2035)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL PROSTHETIC HEART VALVE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023 AND 2035(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 15. PROSTHETIC HEART VALVE MARKET BY REGION, 2023 AND 2035(%)
  • FIGURE 16. U.S. PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 17. CANADA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 18. MEXICO PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 19. GERMANY PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 20. FRANCE PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 21. UK PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 22. ITALY PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 23. SPAIN PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 24. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 25. JAPAN PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 26. CHINA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 27. INDIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 28. AUSTRALIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 29. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 30. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 31. BRAZIL PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 32. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 33. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 34. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 35. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 36. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 37. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 38. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 39. COMPETITIVE DASHBOARD
  • FIGURE 40. COMPETITIVE HEATMAP: PROSTHETIC HEART VALVE MARKET
  • FIGURE 41. TOP PLAYER POSITIONING, 2023